In today's
VETgirl online veterinary continuing education
podcast, we’re diving into a recent study that may reshape how we manage feline infectious peritonitis (FIP), especially around treatment dosing and duration. With growing success using antiviral therapy for this once considered “universally fatal” disease, we now have the opportunity to refine our protocols based on real-world outcomes. So today we are reviewing the exciting findings of this article by Kamiyoshi et al entitled “
High-dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS-441524 and adjunctive mefloquine: 46 cases (2023).”
